These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 22948093)
1. Botulinum toxin A for the treatment of keloids. Gauglitz GG; Bureik D; Dombrowski Y; Pavicic T; Ruzicka T; Schauber J Skin Pharmacol Physiol; 2012; 25(6):313-8. PubMed ID: 22948093 [TBL] [Abstract][Full Text] [Related]
2. Effects of botulinum toxin type A on expression of genes in keloid fibroblasts. Xiaoxue W; Xi C; Zhibo X Aesthet Surg J; 2014 Jan; 34(1):154-9. PubMed ID: 23709452 [TBL] [Abstract][Full Text] [Related]
3. Intralesional triamcinolone alone or in combination with botulinium toxin A is ineffective for the treatment of formed keloid scar: A double blind controlled pilot study. Rasaii S; Sohrabian N; Gianfaldoni S; Hadibarhaghtalab M; Pazyar N; Bakhshaeekia A; Lotti T; Ramirez-Pacheco LA; Lange CS; Matta J; Seifi V; Ramirez-Fort MK; Feily A Dermatol Ther; 2019 Mar; 32(2):e12781. PubMed ID: 30422367 [TBL] [Abstract][Full Text] [Related]
4. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach. Wu CS; Wu PH; Fang AH; Lan CC Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338 [TBL] [Abstract][Full Text] [Related]
5. Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial. Shaarawy E; Hegazy RA; Abdel Hay RM J Cosmet Dermatol; 2015 Jun; 14(2):161-6. PubMed ID: 25810045 [TBL] [Abstract][Full Text] [Related]
6. Exosomes from human adipose-derived mesenchymal stem cells inhibit production of extracellular matrix in keloid fibroblasts via downregulating transforming growth factor-β2 and Notch-1 expression. Li J; Li Z; Wang S; Bi J; Huo R Bioengineered; 2022 Apr; 13(4):8515-8525. PubMed ID: 35333672 [TBL] [Abstract][Full Text] [Related]
7. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts. Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776 [TBL] [Abstract][Full Text] [Related]
8. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway. He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of fibronectin extra domain B suppresses TGF-β1-mediated cell proliferation and collagen deposition in keloid fibroblasts via AKT/ERK signaling pathway. Cui J; Li Z; Jin C; Jin Z Biochem Biophys Res Commun; 2020 Jun; 526(4):1131-1137. PubMed ID: 32317186 [TBL] [Abstract][Full Text] [Related]
10. Zinc-Alpha-2-Glycoprotein Peptide Downregulates Type I and III Collagen Expression via Suppression of TGF-β and p-Smad 2/3 Pathway in Keloid Fibroblasts and Rat Incisional Model. Kim SH; Oh JM; Roh H; Lee KW; Lee JH; Lee WJ Tissue Eng Regen Med; 2024 Oct; 21(7):1079-1092. PubMed ID: 39105875 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option. Dienus K; Bayat A; Gilmore BF; Seifert O Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of genistein ability to modulate CTGF mRNA/protein expression, genes expression of TGFβ isoforms and expression of selected genes regulating cell cycle in keloid fibroblasts in vitro. Jurzak M; Adamczyk K; Antończak P; Garncarczyk A; Kuśmierz D; Latocha M Acta Pol Pharm; 2014; 71(6):972-86. PubMed ID: 25745770 [TBL] [Abstract][Full Text] [Related]
13. mTOR as a potential therapeutic target for treatment of keloids and excessive scars. Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482 [TBL] [Abstract][Full Text] [Related]
15. Effects of botulinum toxin A on patient-specific keloid fibroblasts in vitro. Haubner F; Leyh M; Ohmann E; Sadick H; Gassner HG Laryngoscope; 2014 Jun; 124(6):1344-51. PubMed ID: 24122729 [TBL] [Abstract][Full Text] [Related]
16. The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblasts. Gauglitz GG; Bureik D; Zwicker S; Ruzicka T; Wolf R Skin Pharmacol Physiol; 2015; 28(3):115-23. PubMed ID: 25502330 [TBL] [Abstract][Full Text] [Related]
17. TGF-beta1 increases cell rigidity by enhancing expression of smooth muscle actin: keloid-derived fibroblasts as a model for cellular mechanics. Lee CH; Hong CH; Chen YT; Chen YC; Shen MR J Dermatol Sci; 2012 Sep; 67(3):173-80. PubMed ID: 22771320 [TBL] [Abstract][Full Text] [Related]
18. A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro. Huang L; Cai YJ; Lung I; Leung BC; Burd A J Plast Reconstr Aesthet Surg; 2013 Sep; 66(9):e251-9. PubMed ID: 23810214 [TBL] [Abstract][Full Text] [Related]
19. Activating transcription factor 3 (ATF3) regulates cell growth, apoptosis, invasion and collagen synthesis in keloid fibroblast through transforming growth factor beta (TGF-beta)/SMAD signaling pathway. Wang XM; Liu XM; Wang Y; Chen ZY Bioengineered; 2021 Dec; 12(1):117-126. PubMed ID: 33315500 [TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Lee TY; Chin GS; Kim WJ; Chau D; Gittes GK; Longaker MT Ann Plast Surg; 1999 Aug; 43(2):179-84. PubMed ID: 10454326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]